BSX · News · 20260819N

Market Demand Trends

BOSTON SCIENTIFIC CORP · 2026-08-19 · Importance 40 · Surprise 56

The global cardiovascular devices market is projected to grow from $72.4 billion in 2025 to $101.6 billion by 2030, representing approximately 40% expansion. Growth is expected to be driven by an aging population, increased disease prevalence, minimally invasive procedures, and remote monitoring. Leadless pacemakers, pulsed field ablation, and AI-enabled cardiac monitoring are identified as key growth areas, with Boston Scientific, Abbott, and Medtronic among the dominant participants.

Key facts

• Great Lakes Advisors LLC purchased 279,760 shares of Boston Scientific valued at approximately $11.9 million. source
• Boston Scientific reported an EPS of $0.86 that exceeded estimates. source
• Institutional ownership in Boston Scientific reached 89.07%. source
• Boston Scientific shares rose 3.05% to $52.01 on Wednesday. source